Company: OXBRW
Filing Date: 2025-07-10
Form Type: 424B5
Source: 0001641172-25-018473
Chunk: 16

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-07-10
Form: 424B5
Chunk 16
---
 Plans; |

| ● | 1,411,768                                                                                     
 ordinary shares issuable upon exercise of the ordinary share warrants, with an exercise price 
 of $4.25 per share; and                                                                       |

| ● | 8,230,700                                                                                    
 of our ordinary shares reserved for issuance upon exercise of our outstanding warrants, with 
 an exercise price of $7.50 per share;                                                        |

Each $1.00 increase in the assumed public offering price of $2.27 per share, which was the closing price of our ordinary shares on The Nasdaq Capital Market on July 2, 2025, would increase our as adjusted net tangible book value per share after this offering by an additional $0.04, which at an assumed offering price of $3.27 per share would result dilution to investors participating in this offering of $2.28, assuming that the dollar amount of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. On the other hand, each $1.00 decrease in the assumed public offering price of $2.27 per share would increase our as adjusted net tangible book value per share after this offering by an additional $0.01, which at an assumed offering price of $1.27 would result in dilution per share to investors participating in this offering of $0.31 per share, respectively, assuming that the number of ordinary shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.

To the extent that outstanding warrants or options are exercised, you will experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our shareholders.

| S-6 |

<div align='center'>Plan of Distribution</div>

We
have entered into the Sales Agreement with Maxim as the Agent, under which we may issue and sell shares of our ordinary shares, through
the Agent, having an aggregate gross sales price of up to $5 million from time to time. Pursuant to General Instruction I.B.6 of Form
S